Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Apalutamide 60mg Tab
Abiraterone Acetate 250mg
+4 more
Locations
9
United States
University of California Davis
Sacramento, California, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
University of Michigan Health
Ann Arbor, Michigan, United States
U.T. MD Anderson Cancer Center
Houston, Texas, United States
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Vancouver Prostate Centre
Vancouver, British Columbia, Canada
Start Date
September 21, 2021
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2026
Last Updated
December 16, 2024
NCT06594926
NCT06257264
NCT03620786
NCT05424783
NCT04693377
NCT06190899
Lead Sponsor
University of British Columbia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions